TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15113269

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Metyrapone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 11403338

Group type: EXPERIMENTAL
Intervention: Past interaction frequency
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Future interaction frequency
Number of subjects: 320
Study: 9761224

Group type: EXPERIMENTAL
Intervention: Maltodextrin preload
Number of subjects: 24

Group type: COMPARATOR
Intervention: No-maltodextrin control soup
Number of subjects: 24
Study: 8052481

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (AG)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: AG+MPA
Number of subjects: 85

Group type: COMPARATOR
Intervention: AG, MPA, AG+MPA (all groups)
Number of subjects: 85
Study: 2459557

Group type: EXPERIMENTAL
Intervention: Penticainide (1.5 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Disopyramide (1.5 mg/kg)
Number of subjects: 20
Study: 31830433

Group type: EXPERIMENTAL
Intervention: Knee brace for 2 weeks during daily living, sports, or painful tasks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Educational leaflet with information about PFP
Number of subjects: 50
Study: 30556913

Group type: EXPERIMENTAL
Intervention: Brief interview intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Attention-matched control
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups (neural response to alcohol taste cues)
Number of subjects: 46
Study: 28482740

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Muscular resistance exercise program
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Joint mobility exercise program
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Elastic-band program
Number of subjects: 36

Group type: COMPARATOR
Intervention: Pedaling on a pedal exerciser
Number of subjects: 36

Group type: COMPARATOR
Intervention: Mobility exercises
Number of subjects: 36
Study: 26368295

Group type: EXPERIMENTAL
Intervention: Methadone 10 mg (oral dose)
Number of subjects: 6
Study: 22499082

Group type: EXPERIMENTAL
Intervention: Light-emitting diodes (LEDs)
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Spotlights
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Banks
Number of subjects: 1404

Group type: EXPERIMENTAL
Intervention: Blankets
Number of subjects: 1404
Study: 21292898

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine pyrimetamine (SP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: National IPTp implementation with sulfadoxine pyrimetamine (SP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-trial study with chloroquine prophylaxis
Number of subjects: 0
Study: 18206425

Group type: EXPERIMENTAL
Intervention: OA self-management program
Number of subjects: 519

Group type: COMPARATOR
Intervention: Health education (attention control)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 519
Study: 16856588

Group type: EXPERIMENTAL
Intervention: Only vaginal misoprostol (400 microg 6 hourly up to 4 doses)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Oral plus vaginal misoprostol (400 microg orally at 12 hour intervals for 2 doses, followed by 400 microg vaginally 6 hourly up to 4 doses)
Number of subjects: 54
Study: 14551000

Group type: EXPERIMENTAL
Intervention: World Health Organization table with numbers and categories
Number of subjects: 461

Group type: COMPARATOR
Intervention: Food and Drug Administration table with numbers
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Category table
Number of subjects: 461
Study: 11018309

Group type: EXPERIMENTAL
Intervention: Lipo PGE1 injection
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Constant rate infusion of PGE1 (10 ng kg(‐1) min(‐1))
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Constant rate infusion of PGE1 (50 ng kg(‐1) min(‐1))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 10
Study: 9296473

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin dalteparin (Fragmin) for 3 months
Number of subjects: 3100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3100

Group type: EXPERIMENTAL
Intervention: Direct invasive strategy
Number of subjects: 3100

Group type: COMPARATOR
Intervention: Stepwise selective approach
Number of subjects: 3100

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin dalteparin (Fragmin)
Number of subjects: 3100
Study: 7690219

Group type: EXPERIMENTAL
Intervention: Propafenone 600 mg/d (bid)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Propafenone 600 mg/d (tid)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 3519976

Group type: EXPERIMENTAL
Intervention: Stress inoculation training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-education
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 0
Study: 31618115

Group type: EXPERIMENTAL
Intervention: PICO dressing
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard dressing
Number of subjects: 188
Study: 30057892

Group type: EXPERIMENTAL
Intervention: Rehabilitation programme (exercise 1 h, twice weekly; education 1 h, once weekly)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual medical care (UMC)
Number of subjects: 16
Study: 27756928

Group type: EXPERIMENTAL
Intervention: Team-based learning (TBL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 30
Study: 26227393

Group type: EXPERIMENTAL
Intervention: Mean amplitude of glycemic excursion (MAGE) measured using continuous glucose monitoring system (CGMS)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: MAGE as an independent predictor of rapid progression (RP)
Number of subjects: 88
Study: 22475430

Group type: EXPERIMENTAL
Intervention: Acute watercress supplementation (consumption 2 h before exercise)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Chronic watercress supplementation (8 weeks consumption)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no ingestion)
Number of subjects: 10
Study: 21122057

Group type: EXPERIMENTAL
Intervention: Aliskiren/HCT 150/12.5mg
Number of subjects: 688

Group type: COMPARATOR
Intervention: Aliskiren 150mg
Number of subjects: 688

Group type: EXPERIMENTAL
Intervention: Aliskiren/HCT
Number of subjects: 688

Group type: COMPARATOR
Intervention: Aliskiren
Number of subjects: 688
Study: 18468543

Group type: EXPERIMENTAL
Intervention: ASSIST intervention (peer-led smoking prevention program)
Number of subjects: 10730
Study: 16644344

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study: 12715402

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11012557

Group type: EXPERIMENTAL
Intervention: Z13752A 200 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Z13752A 400 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Z13752A 600 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Z13752A 800 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Z13752A (all doses tested)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Z13752A (200-800 mg range)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 8697547

Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms.ml‐1 with bupivacaine 0.015% and epinephrine 2 micrograms.ml‐1
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sufentanil 1 microgram.ml‐1 with bupivacaine 0.015% and epinephrine 2 micrograms.ml‐1
Number of subjects: 100
Study: 1384443

Group type: EXPERIMENTAL
Intervention: Intestine only
Number of subjects: 17

Group type: COMPARATOR
Intervention: Liver-intestine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Multivisceral graft
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Overall transplantation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Intestinal anastomotic leak
Number of subjects: 17
Study: 6435443

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (infused intravenously)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Intragastric nutrition (infused intragastrically)
Number of subjects: 5
Study: 31645472

Group type: EXPERIMENTAL
Intervention: Phenylephrine administered intravenously to increase systolic blood pressure (SBP) up to 200 mm Hg
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (no induced hypertension)
Number of subjects: 153
Study: 28193176

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure (BP) alone
Number of subjects: 1110

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood pressure with telemonitoring
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1110
Study: 27183072

Group type: EXPERIMENTAL
Intervention: Intrasulcular incision
Number of subjects: 40

Group type: COMPARATOR
Intervention: Trapezoidal incision
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Total sample analysis
Number of subjects: 40
Study: 24626270

Group type: EXPERIMENTAL
Intervention: Chest compression with a 10‐cmH2O increase in baseline inspiratory pressure on pressure support ventilation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Aspiration alone (control group)
Number of subjects: 34
Study: 22395672

Group type: COMPARATOR
Intervention: HAART (stavudine, lamivudine, and nevirapine)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: HAART and chemotherapy (CXT) (Triomune plus bleomycin, doxorubicin, and vincristine every 3 weeks, or oral etoposide when not available)
Number of subjects: 112

Group type: COMPARATOR
Intervention: HAART (Control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: HAART and CXT (Experimental)
Number of subjects: 112
Study: 19775480

Group type: EXPERIMENTAL
Intervention: Irinotecan-containing adjuvant chemotherapy
Number of subjects: 498

Group type: COMPARATOR
Intervention: Adjuvant 5-FU-based chemotherapy (including irinotecan)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Topoisomerase I expression
Number of subjects: 498
Study: 17213294

Group type: EXPERIMENTAL
Intervention: 2 item stage of change (SOC) questionnaire administered prior to ART and after 16 weeks of treatment
Number of subjects: 31
Study: 16366041

Group type: EXPERIMENTAL
Intervention: Verum (thyme fluid extract and primrose root tincture)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Verum
Number of subjects: 150
Study: 17044538

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) applied with Merocel soaked with 1.5 mL of MMC (0.4 mg/mL) for 5 minutes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline solution applied as control
Number of subjects: 20
Study: 10234495

Group type: EXPERIMENTAL
Intervention: Deep anaesthesia removal of laryngeal mask airway
Number of subjects: 300

Group type: COMPARATOR
Intervention: Awake removal of laryngeal mask airway
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Awake removal of laryngeal mask airway in children < 6 years
Number of subjects: 300

Group type: COMPARATOR
Intervention: Deep anaesthesia removal of laryngeal mask airway in children < 6 years
Number of subjects: 300
Study: 8678002

Group type: EXPERIMENTAL
Intervention: Triple therapy plus omeprazole (amoxicillin 500 mg p.o., t.i.d.; metronidazole 250 mg p.o., t.i.d.; bismuth subsalicylate 524 mg p.o., q.i.d.; omeprazole 20 mg p.o., q.d.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Triple therapy plus omeprazole
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: H. pylori-eradicated patients
Number of subjects: 100
Study: 1668656

Group type: EXPERIMENTAL
Intervention: sCT 100 I.U. by nasal spray
Number of subjects: 6

Group type: COMPARATOR
Intervention: sCT 50 I.U. by intramuscular route
Number of subjects: 6
Study: 6346399

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study: 31729520

Group type: EXPERIMENTAL
Intervention: Purple rice
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Yunlu29 (red rice)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Brown rice
Number of subjects: 24
Study: 29879045

Group type: EXPERIMENTAL
Intervention: Qingfeijianpi decoction (1 dose/day for 4 weeks)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Loratadine (10 mg once per day for 4 weeks)
Number of subjects: 101
Study: 27149266

Group type: EXPERIMENTAL
Intervention: RIX4414
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: DTPa and OPV (co-administered with RIX4414)
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: OPV (co-administered with RIX4414)
Number of subjects: 786
Study: 25227994

Group type: EXPERIMENTAL
Intervention: Acute Tryptophan Depletion (ATD)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 22777514

Group type: EXPERIMENTAL
Intervention: Etomidate
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (among etomidate-exposed patients)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Control (No etomidate)
Number of subjects: 149
Study: 19815243

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg/d, n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Metformin (maximum dose 2550 mg/d, n = 50)
Number of subjects: 100
Study: 16876479

Group type: EXPERIMENTAL
Intervention: Group 1 (G(1), N=6): 8 x 60% of T(max) at V.VO(2max), 1:1 work:recovery ratio
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Group 2 (G(2), N=6): 12 x 30s at 130% V.VO(2max), 4.5 min recovery
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (G(CON), N=5): 60 min at 75% V.VO(2max)
Number of subjects: 17
Study: 16236956

Group type: EXPERIMENTAL
Intervention: Low amount/moderate intensity (LAMI, n = 25)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Low amount/high intensity (LAHI, n = 36)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: High amount/high intensity (HAHI, n = 35)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group (n = 37)
Number of subjects: 133
Study: 12119808

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment technique (ART) using hand instruments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment technique using rotary instruments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement restorations made with hand instruments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fissure sealant retention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Operator variances
Number of subjects: 0
Study: 9917435

Group type: EXPERIMENTAL
Intervention: Combined vaccine (DTaP + PRP-T)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Separate vaccines (DTaP and PRP-T)
Number of subjects: 135
Study: 7482998

Group type: EXPERIMENTAL
Intervention: Chloroquine 300 mg weekly combined with proguanil 100 mg daily
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Chloroquine 300 mg weekly combined with proguanil 200 mg daily
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Proguanil 200 mg daily only
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Fever incidence
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Compliance assessment
Number of subjects: 200
Study: 31095461

Group type: EXPERIMENTAL
Intervention: NO3‐ rich beetroot juice (12.9 mmol NO3‐)
Number of subjects: 12

Group type: COMPARATOR
Intervention: NO3‐ depleted placebo (0.13 mmol NO3‐)
Number of subjects: 12
Study: 28194729

Group type: EXPERIMENTAL
Intervention: Decision support tool and order set for inpatient physicians
Number of subjects: 10939

Group type: COMPARATOR
Intervention: Control group (no decision support tool)
Number of subjects: 10939
Study: 26051163

Group type: EXPERIMENTAL
Intervention: Motivational 'Lung Age' feedback
Number of subjects: 225

Group type: COMPARATOR
Intervention: Minimal feedback (Control)
Number of subjects: 225
Study: 23423433

Group type: EXPERIMENTAL
Intervention: Killed Leishmania (Leishmania) amazonensis vaccine
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 22189927

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 18036764

Group type: EXPERIMENTAL
Intervention: Pedometer with cognitive and behavioral support materials (n=51)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Pedometer without cognitive and behavioral support materials (n=52)
Number of subjects: 103
Study: 15921331

Group type: EXPERIMENTAL
Intervention: LongoVital (LV)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11887037

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) therapy and Selenium (Se) supplementation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Erythropoietin (EPO) alone
Number of subjects: 3

Group type: COMPARATOR
Intervention: Selenium (Se) supplementation
Number of subjects: 3
Study: 10703146

Group type: EXPERIMENTAL
Intervention: Intrastromal corneal ring segments (ICRS)
Number of subjects: 74
Study: 9170575

Group type: EXPERIMENTAL
Intervention: Flutamide 250 mg (125 mg x 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flutamide 375 mg (125 mg x 3)
Number of subjects: 30
Study: 1751811

Group type: EXPERIMENTAL
Intervention: Rifaximin (400 mg/8h)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neomycin (1gr/8h)
Number of subjects: 30
Study: 6627697

Group type: EXPERIMENTAL
Intervention: Morphine (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoclopramide (10 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Benserazide (200 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoclopramide (1 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Benserazide
Number of subjects: 0
Study: 31783823

Group type: EXPERIMENTAL
Intervention: Daily oral esketamine as add-on to regular antidepressant medications for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo as add-on to regular antidepressant medications for 6 weeks
Number of subjects: 0
Study: 30541593

Group type: COMPARATOR
Intervention: Clinical information-based fluid management
Number of subjects: 244
Study: 27239794

Group type: EXPERIMENTAL
Intervention: Process and mortality reporting (2008-2012)
Number of subjects: 20707266

Group type: COMPARATOR
Intervention: Process-only reporting (2005-2007)
Number of subjects: 20707266

Group type: COMPARATOR
Intervention: Nonreported conditions (secular control)
Number of subjects: 20707266
Study: 25046410

Group type: EXPERIMENTAL
Intervention: Grosse‐Kempf nail
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Russell‐Taylor nail
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Synthes nail
Number of subjects: 84
Study: 22101419

Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopy (SILS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional Laparoscopy
Number of subjects: 20
Study: 19290703

Group type: EXPERIMENTAL
Intervention: Contingency management (CM) plus standard methadone treatment for 12 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: Standard methadone treatment
Number of subjects: 191
Study: 18416737

Group type: EXPERIMENTAL
Intervention: basiliximab, calcineurin inhibitor, sirolimus and steroids
Number of subjects: 274
Study: 15747721

Group type: EXPERIMENTAL
Intervention: Supplementary enteral nutrition through nasogastric tube
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional liquid diet
Number of subjects: 32
Study: 12014813

Group type: EXPERIMENTAL
Intervention: Treatment Reinforcement Plan (TRP) - rewarded up to $15 per week for task completion
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Treatment Reinforcement Plan (TRP)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tasks related to therapy attendance
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tasks related to obtaining public entitlements
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tasks related to medical/psychiatric appointments
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tasks related to obtaining Medicaid
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tasks related to HIV testing/education
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tasks related to managing money
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tasks related to legal matters
Number of subjects: 57
Study: 10408073

Group type: EXPERIMENTAL
Intervention: Estradiol patch 0.05 mg daily for 3 weeks (Group 1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: No hormone replacement (Group 2)
Number of subjects: 42
Study: 7500464

Group type: EXPERIMENTAL
Intervention: Transurethral evaporation of the prostate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Visual laser ablation of the prostate
Number of subjects: 64
Study: 2149049

Group type: EXPERIMENTAL
Intervention: Teicoplanin plus aztreonam
Number of subjects: 70

Group type: COMPARATOR
Intervention: Gentamicin plus piperacillin
Number of subjects: 70
Study: 394794

Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate injections
Number of subjects: 57

Group type: COMPARATOR
Intervention: Flupenthixol decanoate injections
Number of subjects: 57
Study: 29804484

Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation of umbilical cord lengths using a new method
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation for predicting short umbilical cords
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation for predicting long umbilical cords
Number of subjects: 681
Study: 30285695

Group type: EXPERIMENTAL
Intervention: Oxygen-driven nebulisation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Air-driven nebulisation
Number of subjects: 90
Study: 26755543

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 0
Study: 25259426

Group type: EXPERIMENTAL
Intervention: Topical ketorolac (n=46)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo (n=59)
Number of subjects: 105
Study: 22407900

Group type: EXPERIMENTAL
Intervention: Dong-Kook Montelukast Sodium Chewable Tablet 5 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Singulair Chewable Tablet 5 mg
Number of subjects: 32